Gastroenteropancreatic Neuroendocrine Tumors. Ten Year Experience at Instituto Oncologico Nacional. Panama 2004-2015.
#1384
Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NET) are rare neoplasm with a rising incidence worldwide.
Aim(s): The aim of this study was to analyze demographic, tumor, therapy, and clinical outcomes of patients presenting with GEP-NET in our institution
Materials and methods: The cases of 152 patients with histological proven GEP-NET evaluated between 2004 and 2015 were reviewed retrospectively.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Castillo-Fernandez O, Vergara R, Moreno-Ríos J, Cukier M, Tapia H,
Keywords: grade, prognosis, neuroendocrine tumor,
To read the full abstract, please log into your ENETS Member account.